Publications
27 publications
Funding
4 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPIU54CA221704-08Pilot Research Project: Evaluating Breast Cancer Patient Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signalingNCI · 2018–2028 · via NIH RePORTER
- PIR01CA239603-05The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast CancerNCI · 2020–2026 · via NIH RePORTER
Completed grants (2)
- PISC1CA137843-04p53-Independent Cell Death Signaling by Mitomycin DNA AdductsNCI · 2008–2012 · via NIH RePORTER
- MPIS06GM060654-08Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family MembersNIGMS · 2000–2008 · via NIH RePORTER